Jeffrey Bluestone
Director · GILEAD SCIENCES, INC.
IndividualSelling only12 10b5-1 trades
- 2024
- Aug 21, 2026
- 5
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey Bluestone files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
- Johanna Mercier - $18.17M in GILD purchases and sales in the last 12 months
- Deborah H. Telman - $6.59M in GILD purchases and sales in the last 12 months
- Andrew D. Dickinson - $4.38M in GILD purchases and sales in the last 12 months
- Anthony Welters - $2.68M in GILD purchases and sales in the last 12 months
- Kelly A. Kramer - $713K in GILD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey Bluestone?
Jeffrey Bluestone is a corporate insider, tracked as Director of GILEAD SCIENCES, INC. (GILD). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeffrey Bluestone submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jeffrey Bluestone been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($2.52M) across all tracked filings.
